There is a wealth of information in the literature about the effects of OCPs on glucose tolerance and insulin sensitivity in women with PCOS, indicating that OCPs have a negative impact on these parameters, which can lead to an increased long-term risk of metabolic disorders such as type 2 diabetes mellitus (T2DM), IR and CVD [43–46]. This evidence concerns the gene INS and metabolic disease.